Comparative efficacy of risperidone and clozapine in the treatment of patients with refractory schizophrenia or schizoaffective disorder: A retrospective analysis

Journal of Clinical Psychiatry

Volumn 61, Issue 7, 2000, Pages 498-504

  Sharif, Zafar A ^a,b   Raza, Ahmad ^a,b   Ratakonda, Santhi S ^c  

^a Creedmoor Psychiatric Center   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c ELMHURST HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; RISPERIDONE;

ADULT; AGGRESSION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HUMAN; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; RATING SCALE; RISK BENEFIT ANALYSIS; SCHIZOIDISM; SCHIZOPHRENIA;

EID: 0033931485     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0707     Document Type: Article

References (21)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
2. Lieberman JA, Safferman AZ, Pollack S, et al. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994;151:1744-1752
3. Conley RR, Carpenter WT Jr, Tamminga CA. Time to clozapine response in a standardized trial. Am J Psychiatry 1997;154:1243-1247
4. Small J, Miller M, Klapper M, et al. Risperidone versus clozapine in resistant schizophrenia. Poster presented at the 146th annual meeting of the American Psychiatric Association; May 22-27, 1993; San Francisco, Calif
5. Daniel DG, Goldberg TE, Weinberger DR, et al. Different side effect profile of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study. Am J Psychiatry 1996;153:417-419
6. Bondolfi G, Dufour H, Patris M, et al. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized, double-blind study. Am J Psychiatry 1998;155:499-504
7. Breier AF, Malhotra AK, Su TP, et al. Clozapine and risperidone in chronic schizophrenia: effect on symptoms, parkinsonian side effects, and neuroendocrine response. Am J Psychiatry 1999;156:294-298
8. Lindenmayer J-P, Iskander A, Park M, et al. Clinical and neurocognitive effects of clozapine and risperidone in treatment-refractory schizophrenic patients: a prospective study. J Clin Psychiatry 1998;59:521-527
9. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
10. Conley RR, Tamminga CA, Bartko JJ, et al. Olanzapine compared with chlorpromazine for treatment-resistant schizophrenia. Am J Psychiatry 1998;155:914-920
11. Breier A, Buchanan RW, Kirkpatrick B, et al. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994;151:20-26
12. Meltzer HY, Bastani B, Kwon KY, et al. A prospective study of clozapine in neuroleptic-resistant schizophrenia. Am J Psychiatry 1993;150: 1630-1638
13. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
14. Czobor P, Volavka J, Meibach R. Effect of risperidone on hostility in schizophrenia. J Clin Psychopharmacol 1995;15:243-249
15. Chouinard G, Jones B, Remington G, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J Clin Psychopharmacol 1993;13:25-40
16. Marder S, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
17. Glazer WM, Dickson RA. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 1998;59(suppl 3):8-14
18. Wirshing DA, Barringer MD, Green MF, et al. Risperidone in treatment-refractory schizophrenia. Am J Psychiatry 2000;156:1374-1379
19. Leadbetter RA, Shutty MS Jr. Differential effects of neuroleptics and clozapine on polydipsia and intermittent hyponatremia. J Clin Psychiatry 1994;55(9, suppl B):110-113
20. Goldman MB, Robertson GL, Luchins DJ, et al. Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia. Arch Gen Psychiatry 1997;54:443-449
21. Davis JM, Janicak PG. Risperidone: a new, novel (and better?) antipsychotic. Psychiatr Ann 1996;26:78-87